Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8+ T Cell Cross-Priming by van Dinther, Dieke et al.
                                                              
University of Dundee
Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8+
T Cell Cross-Priming
van Dinther, Dieke; Veninga, Henrike; Iborra, Salvador; Borg, Ellen G. F.; Hoogterp, Leoni;
Olesek, Katarzyna; Beijer, Marieke R.; Schetters, Sjoerd T. T.; Kalay, Hakan; Garcia-Vallejo,
Juan J.; Franken, Kees L.; Cham, Lamin B.; Lang, Karl S.; van Kooyk, Yvette; Sancho, David;
Crocker, Paul R.; den Haan, Joke M. M.
Published in:
Cell Reports
DOI:
10.1016/j.celrep.2018.01.021
Publication date:
2018
Document Version
Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
van Dinther, D., Veninga, H., Iborra, S., Borg, E. G. F., Hoogterp, L., Olesek, K., ... den Haan, J. M. M. (2018).
Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8+ T Cell Cross-Priming.
Cell Reports, 22(6), 1484-1495. DOI: 10.1016/j.celrep.2018.01.021
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Article
Functional CD169 on Macrophages Mediates
Interaction with Dendritic Cells for CD8+ T Cell
Cross-Priming
Graphical Abstract
Highlights
d CD169+ macrophages rely on BATF3-dependent DCs to
cross-prime CD8+ T cells
d DNGR-1 on cDC1s improves cross-priming to antigens
targeted to CD169+ macrophages
d CD169 binds to sialic acids on CD8a+ DCs
d CD169 binding promotes T cell priming after non-replicative
vaccinia virus infection
Authors
Dieke van Dinther, Henrike Veninga,
Salvador Iborra, ..., David Sancho,
Paul R. Crocker, Joke M.M. den Haan
Correspondence
j.denhaan@vumc.nl
In Brief
van Dinther et al. find that splenic CD169+
macrophages transfer antigens to
BATF3-dependent cDC1s in a CD169-
dependent manner and that these cDC1s
cross-prime CD8+ T cell responses in a
DNGR-1-dependent manner.
MΦ
MΦ
AgA
g
DCDCMΦ
antiCD169
DC
T cell
T cell
T cell
T cell
T cell
T cell
T cell
DNGR1,  
Batf3 dependent
No CD169 - ligand 
interaction
T cell response
No T cell response
No Batf3 dependent DCs 
Lower T cell response
No DNGR1
T cell
T cell
T cell
T cell
antiCD169
antiCD169
CD169 dependent
AgA
g Ag
Ag
Modified 
Vaccinia 
Ankara
T cell
T cell
T cell
T cell
T cell
T cell
T cell
MVA
van Dinther et al., 2018, Cell Reports 22, 1484–1495
February 6, 2018 ª 2018 The Authors.
https://doi.org/10.1016/j.celrep.2018.01.021
Cell Reports
Article
Functional CD169 on Macrophages
Mediates Interaction with Dendritic Cells
for CD8+ T Cell Cross-Priming
Dieke van Dinther,1,6 Henrike Veninga,1,6 Salvador Iborra,2 Ellen G.F. Borg,1 Leoni Hoogterp,1 Katarzyna Olesek,1
Marieke R. Beijer,1 Sjoerd T.T. Schetters,1 Hakan Kalay,1 Juan J. Garcia-Vallejo,1 Kees L. Franken,3 Lamin B. Cham,4
Karl S. Lang,4 Yvette van Kooyk,1 David Sancho,2 Paul R. Crocker,5 and Joke M.M. den Haan1,7,*
1Cancer Center Amsterdam, Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, the
Netherlands
2Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain
3Department of Immunohematology and Bloodtransfusion, LUMC, Leiden, the Netherlands
4Institute of Immunology, Medical Faculty, University Duisburg-Essen, 45122 Essen, Germany
5Division of Cell Signalling and Immunology, University of Dundee, Dundee, UK
6These authors contributed equally
7Lead Contact
*Correspondence: j.denhaan@vumc.nl
https://doi.org/10.1016/j.celrep.2018.01.021
SUMMARY
Splenic CD169+ macrophages are located in the
marginal zone to efficiently capture blood-borne
pathogens. Here, we investigate the requirements
for the induction of CD8+ T cell responses by anti-
gens (Ags) bound by CD169+ macrophages. Upon
Ag targeting to CD169+ macrophages, we show
that BATF3-dependent CD8a+ dendritic cells (DCs)
are crucial for DNGR-1-mediated cross-priming of
CD8+ T cell responses. In addition, we demonstrate
that CD169, a sialic acid binding lectin involved in
cell-cell contact, preferentially binds to CD8a+ DCs
and that Ag transfer to CD8a+ DCs and subsequent
T cell activation is dependent on the sialic acid-
binding capacity of CD169. Finally, functional
CD169 mediates optimal CD8+ T cell responses to
modified vaccinia Ankara virus infection. Together,
these data indicate that the collaboration of CD169+
macrophages and CD8a+ DCs for the initiation of
effective CD8+ T cell responses is facilitated by
binding of CD169 to sialic acid containing ligands
on CD8a+ DCs.
INTRODUCTION
While lymph nodes receive antigen (Ag) via the afferent lymph
vessels, the spleen filters the blood in the marginal zone and
red pulp. Macrophages characterized by high expression of
CD169, also known as Sialoadhesin or sialic acid-binding immu-
noglobulin-like lectin-1 (Siglec-1), are situated at both sites of Ag
entry, the subcapsular sinus and marginal sinus (Martinez-
Pomares and Gordon, 2012). An intact layer of CD169+ macro-
phages is necessary for removal of pathogens and prevention
of further spreading of infection (Gupta et al., 2016; Iannacone
et al., 2010; Junt et al., 2007; Seiler et al., 1997) and they rapidly
stimulate several innate lymphoid cell types, thereby promoting
an early wave of innate host defense (Barral et al., 2010;
Kastenm€uller et al., 2012; Kawasaki et al., 2013).
CD169+ macrophages are situated on top of B cell follicles,
take up Ag such as immune complexes and viruses, present
these Ags in intact form to follicular B cells, and induce germinal
center B cell responses (Berney et al., 1999; Carrasco and
Batista, 2007; Junt et al., 2007; Phan et al., 2007, 2009; Veninga
et al., 2015). However, the role of CD169+ macrophages in the
priming of CD8+ T cell responses is debated (Asano et al.,
2011; Backer et al., 2010; Bernhard et al., 2015).
CD169+ macrophages are frequently the primary cell type in-
fected during a viral infection (Eloranta and Alm, 1999; Iannacone
et al., 2010) and while the CD169 molecule itself acts as a viral
receptor (Delputte et al., 2007; Erikson et al., 2015; Puryear
et al., 2013; Sewald et al., 2015), CD169+ macrophages
are generally considered dispensable for the initiation of T cell
responses (Aichele et al., 2003; Winkelmann et al., 2014).
CD169+ macrophages have been shown to allow viral replica-
tion, which results in high amounts of viral Ags and amplification
of T and B cell responses (Honke et al., 2011). This suggests that
pathogen uptake and Ag generation are the main functions of
CD169+ macrophages, while dendritic cells (DCs) are essential
for CD8+ T cell priming (den Haan et al., 2000; Jung et al.,
2002; Segura and Amigorena, 2015). In our previous studies,
we observed Ag presentation to CD8+ T cells by cross-present-
ing CD8a+ DCs (classical DC1, cDC1) when Ag was targeted to
CD169+ macrophages (Backer et al., 2010). Recently, Bernhard
et al. (2015) showed that after adenoviral infection of CD169+
macrophages, long-lived Ag was cross-presented by CD8a+
DCs to CD8+ T cells. Together, these studies indicate a func-
tional collaboration between CD169+ macrophages and cross-
presenting DCs in the activation of CD8+ T cells and imply an
interaction between the two cell types to enable Ag transfer.
However, the molecular interactions involved in this process
are completely unknown.
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One of the molecules indicated to play a role in cellular
communication is CD169 itself. CD169 is a lectin receptor that
binds sialylated glycoproteins and glycolipids on both endoge-
nous cells as well as pathogens (Crocker and Gordon, 1989;
Crocker et al., 1994; Macauley et al., 2014). In previous studies,
CD169 has been shown to mediate binding to neutrophils and to
innate-like lymphocytes (Crocker et al., 1995; van den Berg et al.,
1992; Zhang et al., 2016). In the present study, we find that, when
Ags are specifically targeted to CD169+ macrophages, presen-
tation by BATF3-dependent cross-presenting DCs is essential
for cross-priming of CD8+ T cells. Our studies demonstrate
that CD169 is involved in Ag transfer to CD8a+ DCs and priming
of CD8+ T cells. Finally, the activation of non-replicative vaccinia
virus-specific CD8+ T cells is hampered when the binding activity
of CD169 was blocked. These results indicate that CD169+
macrophages interact with DC1s in a CD169-dependent manner
and that this interaction enhances BATF3-dependent, DNGR-1-
mediated cross-priming of CD8+ T cells.
RESULTS
T Cell Responses after Ag Targeting to CD169+
Macrophages Rely on BATF3-Dependent DCs
Previously, we showed that Ag targeting to CD169+ macro-
phages resulted in Ag presentation by CD8a+ DCs to CD8+
T cells (Backer et al., 2010). To investigate the requirement of
cross-presenting DCs to present Ags bound by CD169+ macro-
phages, we used BATF3-deficient mice, which contain signifi-
cantly decreased numbers of cross-presenting CD8a+ DCs,
but do contain normal frequencies of CD169+ macrophages
(Figures S1A and S1B) (Hildner et al., 2008). We immunized
wild-type (WT) and BATF3-deficient mice with antibody
(Ab)-ovalbumin (OVA) conjugates targeted to DEC205+CD8a+
DCs or CD169+ macrophages in the presence of adjuvants.
Both OVA targeting to DEC205 or CD169 induced OVA-specific
effector and memory CD8+ and CD4+ T cells in a BATF3-
dependent manner (Figures 1A, 1B, and S1C). These results
demonstrate that CD169+ macrophages do not cross-present
exogenous Ags and that T cell cross-priming relies on cross-
presenting DCs.
Because Ag transfer between CD169+ macrophages and
DCs would imply physical interactions between these cells, we
determined the localization of DCs and CD169+ macrophages in
mice injected with Alexa 488-labeled anti-CD169 (aCD169-488)
Ab plus adjuvant by fluorescence microscopy. DCs and CD169+
macrophages were located in close contact with each other,
and the injected Ab was observed on contact points between
the macrophages and the DCs (Figure 1C). Staining for XCR1,
which is a unique marker for BATF3-dependent DCs, demon-
strated multiple interactions between XCR1+ cDC1s with
CD169+macrophagescarryingCD169-488 (Figure1D). Together,
these results indicate colocalization between CD169+ macro-
phages and cross-presenting DCs, and we hypothesize that this
interaction would enable Ag transfer.
We and others have observed that CD8a+ DCs show some
CD169 staining after isolation using enzymatic digestion (Fig-
ure S1D) (Segura et al., 2010). If CD8a+ DCs would express
CD169 molecules, then direct targeting to DCs would be
possible. However, we and others did not detect CD169 RNA
expression in sorted CD8a+ DCs (Figure S1E) (GEO: GSE6259)
(Dudziak et al., 2007). The presence of CD169 on other cell types
can be caused by the isolation procedure (Zhang et al., 2016). To
exclude this phenomenon, we used multiplex confocal micro-
scopy, 3D image surface rendering, and subsequent histocy-
tometry analysis ofmurine spleens to quantify CD169 expression
ex vivo on APC subsets. This analysis showed no expression of
CD169 by DC subsets in spleen sections (Figure 1E). Together,
these results suggest that CD8a+ DCs do not express CD169,
but do interact with CD169+ macrophages and are essential
for the activation of CD8+ T cell responses.
Ags Bound by CD169+ Macrophages Are Transferred to
CD8a+ DCs
To investigate Ag transfer between CD169+ macrophages and
DCs, we analyzed the transfer of aCD169-488 to DCs in the pres-
ence of adjuvant by flow cytometry. At 10 min after injection, half
of the macrophages were labeled with fluorescent Ab (Figures
S2A and S2B), while this was negligible for CD8a+, CD4+, or dou-
ble negative (DN) DCs (Figures 2A–2C). Two hours after immuni-
zation, 75% of the macrophages (Figures S2A and S2B) and
15%–20% of CD8a+ DCs and DN DCs, and to a lower extent
CD4+ DCs, were labeled (Figures 2A–2C). The increase in
mean fluorescence was highest in CD8+ DCs at different time
points after injection (Figure 2D). Analysis of transferred
aCD169-488 in DC subsets in BATF3-deficient mice revealed
an increase in Ag transfer to CD4+ DCs (Figures 2E–2H). These
results suggest a preferential interaction between CD169+ mac-
rophages with CD8a+ DCs.
Figure 1. T Cell Activation after Ag Targeting to CD169+ Macrophages Requires BATF3-Dependent DCs
(A and B) Percentage of OVA-specific IFNg producing CD8+ (A) and CD4+ (B) CD11a+ T cells after in vitro re-stimulation with H-2Kb-restricted OVA257–264
peptide or I-Ab-restricted OVA262–276 peptide, in C57BL/6 (WT, wild-type) and BATF3-deficient knockout (KO) mice 9 days after immunization (1 mg of
indicated Ab-OVA with 25 mg aCD40 and 25 mg poly(I:C)). Representative flow cytometry plots and mean ± SEM of one representative experiment of
two experiments using 3–5 mice/group. Statistical analysis one-way ANOVA with Bonferroni’s multiple comparison test. *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001; n.s., non-significant.
(C) CD11c (red), injected anti-CD169 (green), CD169 (blue), and in white a co-localization mask of CD11c and CD169 (merge without co-localization mask).
Zoom of the indicated area with cell masks for CD11c (red) and CD169 (blue), co-localization mask (white), and injected anti-CD169 (green). Scale bars, 5 mmand
3 mm in the zoom.
(D) Representative image of CD169+ macrophage interacting with XCR1+ DC. CD11c (red), injected anti-CD169 (green), CD169 (blue), and XCR1 (white).
Scale bars, 25 mm and 10 mm in the zoom.
(E) In situ CD169 expression on splenic macrophages and DC subsets based on multiplex confocal microscopy and 3D image surface rendering of whole spleen
sections (n = 3).
See also Figure S1F.
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Using imaging flow cytometry, CD8a+ DCs were shown to
carry both membrane-associated and intracellular fluorescent
content, indicating uptake of aCD169-488 (Figure 2I). The fluo-
rescence was concentrated in round structures both at the cell
membrane as well as intracellular, which is in line with the
observed binding and uptake of cellular vesicles during the
2 hr after immunization. The combined results of these studies
indicate that Ags are transferred from CD169+ macrophages to
DCs, and the transfer appears to be more efficient to CD8a+
and to DN DCs than to CD4+ DCs.
Figure 2. Ags Targeted to CD169+ Macrophages Are Transferred to DCs
(A–D) Wild-typemice were injected with 1 mg of the indicated Ab-Alexa488 with 25 mg aCD40 and 25 mg poly(I:C). (A) Percentage of Alexa488+ DCs, (B) geometric
mean of Alexa488 signal per DC subset, and (C) representative histogram of eachDC subset at 10min (dotted line) and 2 hr (solid line) after immunization (gray line
isotype control), one representative experiment of two experiments each with 3 mice/group. (D) Geometric mean ± SEM of Alexa488 signal per DC subset on
indicated time points after injection. 3 mice/group.
(E–H) Wild-type mice or BATF3-KOmice were injected with 1 mg of the indicated Ab-Alexa488 with 25 mg aCD40 and 25 mg poly(I:C). (E) Percentage of Alexa488+
DCs and (F) geometric mean of Alexa488 signal per DC subset. (G) percentage of DC subsets per group. (H) 488+ cells per subset as a percentage of total DCs.
Mean ± SEM of one representative experiment of two with 3 mice per group.
(I) Representative images of isolated CD8a+ DCs containing Alexa488 signal 2 hr after Ag targeting. 3 mice per group were pooled, representative of 4 exper-
iments. Negative internalization scores indicate that the majority of Alexa488 signal is membrane-associated, while positive internalization scores indicate
intracellular presence of Alexa488 signal. Statistical analysis one-way ANOVA with Bonferroni’s multiple comparison test. *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001; n.s., non-significant.
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Adjuvant Enhances Ag Transfer from CD169+
Macrophages to CD8a+ DCs
Because all previous experiments were performed in the pres-
ence of adjuvant, we questioned whether Ag transfer was
enhanced by the presence of adjuvant. We detected a decrease
in the percentage and intensity of fluorescent CD8a+ and DN
DCs in mice injected with aCD169-488 without adjuvant,
although still a significant amount of Ag transfer remained (Fig-
ures 3A–3C). To test the functional relevance of Ag transfer in
the absence of adjuvant, we used DCs from mice injected with
aCD169-OVA without adjuvant to stimulate OT-I T cells in vitro.
These DCs provided minimal stimulation for OT-I T cell activa-
tion, even though they could stimulate T cell responses after
exogenous peptide loading, indicating that the DCs did not
have any intrinsic defect to stimulate T cells (Figures 3D and
S3A). In addition, immunization with aCD169-OVA conjugate in
the absence of adjuvant did not lead to OVA-specific T cell re-
sponses in vivo (Figure 3E). Our results demonstrate that adju-
vant enhances Ag transfer from CD169+ macrophages to DCs
and is absolutely essential in the activation of T cell responses.
DNGR-1 Expression onCross-Presenting DCsEnhances
Cross-Priming of CD8+ T Cell Responses
A well-known feature of CD8a+ DCs is that they can efficiently
recognize and cross-present cell-associated Ags from dying
cells (den Haan et al., 2000; Iyoda et al., 2002; Schulz and Reis
e Sousa, 2002). Recently, lymph node CD169+ macrophages
were shown to die and disappear after infection or inflammation
(Gaya et al., 2015; Sagoo et al., 2016). Consistent with this, we
detected a significant decrease in CD169+ macrophages and
migration of the remaining CD169+ macrophages into the B
cell follicles 24 and 48 hr after adjuvant injection, while
aCD169-OVA conjugate in the absence of adjuvant did not
induce this disappearance (Figure 4A). Because macrophages
also quickly die following isolation (Zhang et al., 2016) (Fig-
ure S4A), we hypothesized that they might die upon activation
in vivo and that this process would enhance recognition by
CD8a+ DNGR-1-expressing DCs. DNGR-1 is a C-type lectin re-
ceptor that recognizes F-actin on dead cells and stimulates
cross-presentation of dead-cell-derived material by CD8a+
DCs and the activation of CD8+ T cell responses in viral infections
(Ahrens et al., 2012; Iborra et al., 2012, 2016; Sancho et al.,
2009). Normal numbers of both CD169+ macrophages and DC
were detected in DNGR-1-deficient (Clec9agfp/gfp) mice (Fig-
ure S4B). While Ag transfer from CD169+ macrophages to DCs
was unaffected in DNGR-1-deficient mice (Figures 4B and 4C),
CD8+ T cell responses were significantly lower in DNGR-1-
deficient mice following immunization (Figures 4D and 4E).
These results are in line with previous studies that demonstrated
that DNGR-1 recognition of F-actin is not essential for uptake,
but enhances cross-presentation of cell-associated Ag to
T cells (Sancho et al., 2009; Zelenay et al., 2012). In conclusion,
our data indicate that adjuvants play a relatively minor role in Ag
transfer, but are essential for the activation of CD8+ T cell re-
sponses and may stimulate DNGR-1-mediated cross-priming
of T cells by CD8a+ DC.
CD169Binds to Sialic Acids on CD8a+ DCs, Promotes Ag
Transfer, and T Cell Cross-Priming
The CD169 molecule is a sialic acid binding lectin with a prefer-
ence for a2,3-linked sialic acids that is involved in cellular
interactions (Crocker et al., 1995; van den Berg et al., 1992).
We hypothesized a role for CD169 in DC interaction and Ag
transfer and stained splenocytes with plant lectins that have a
Figure 3. Adjuvant Enhances Antigen Trans-
fer from Macrophages to DCs
(A–C) Wild-type mice were injected with 1 mg of the
indicated Ab-Alexa488 in the presence or absence
of 25 mg aCD40 and 25 mg poly(I:C). (A) Percentage
of Alexa488+ DC subsets and (B) geometric mean of
Alexa488 signal per DC subset 2 hr after injection
using 3 mice/group. (C) Representative histograms
of each DC subset at 2 hr after injection of Ab-
Alexa488 with adjuvant (solid line) or without adju-
vant (dotted line), gray area for the isotype control.
Mean ± SEM of one representative of 2 experiments
is shown.
(D) Wild-type mice were injected with 1 mg of indi-
cated Ab-OVA in the presence or absence of 25 mg
aCD40 and 25 mg poly(I:C). 16 hr later DCs were
used as stimulators for an OT-I proliferation assay,
measured by 3H-Thymidine incorporation. Graph
shows mean counts per minute (CPM) ± SEM of
triplicate co-cultures of 105 OT-I T cells together with
a 3-fold 3-step titration of DCs starting at 2.5 3 105
DCs. One representative experiment of 3 is shown.
(E) Percentage of H-2Kb-SIINFEKL-tetramer+ CD8+
T cells 7 days after immunization. Mean ± SEM of 3
mice per group. Statistical analysis one-way ANOVA
with Bonferroni’s multiple comparison test. *p <
0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; n.s.,
non-significant.
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specificity for a2,3 sialic acids (MAL-II) and a2,6 sialic acids
(SNA) (Figure 5A). DCs showed highest expression of a2,3 sialic
acids compared to B cells and neutrophils, and low expression
of a2,6 sialic acids. Recombinant CD169Fc proteins demon-
strated more binding to DCs than to neutrophils (Figure 5B).
Especially CD8a+ and to a lesser extent CD4+ and DN DCs
boundMAL-II (Figure 5C) and recombinant CD169Fc (Figure 5D).
Binding was dependent on sialic acids as neuraminidase treat-
ment of DCs abrogated the interaction (Figure 5E) and recombi-
nant CD169Fc containing an alanine substitution in the sialic acid
binding domain (R97A) that abolishes sialic acid binding, did not
bind to DCs or to other splenocytes (Figures 5B and 5D) (Vinson
et al., 1996). These data indicate that CD169 on macrophages
can bind to sialic acids on DCs and this may facilitate the
interaction between macrophages and DCs necessary for the
transfer of CD169+ macrophage-derived Ag to cross-presenting
CD8a+ DCs.
To investigate the role of CD169-mediated recognition of
sialic acids in the transfer of Ag and the activation of T cells,
we injected Sn-KI mice expressing a mutated CD169, unable
to bind sialic acids because of the amino acid substitutions
R97A and W2Q, with aCD169-488 and measured the transfer
of aCD169-488 to DCs 2 hr after injection (Klaas et al., 2012).
Sn-KI mice contain normal numbers of the DC subsets and
CD169-expressing macrophages (Figures S5A–S5C). Both the
percentage of Alexa488+ DCs and the MFI on the DC subsets
were decreased by 50% or more in Sn-KI mice (Figures 6A
and 6B). This indicates that Ag transfer between CD169+ mac-
rophages and DCs depends on the presence of functional
sialic-acid binding CD169 on the macrophages. Accordingly,
CD8+ and CD4+ T cell responses following immunization with
aCD169-OVA conjugates were reduced in Sn-KI mice
compared to wild-type mice, whereas immunization with
aDEC205-OVA conjugates was not affected (Figures 6C and
6D). These experiments show that CD169 binds to CD8a+
DCs in a sialic acid-dependent manner, and functional CD169
enhances Ag transfer and contributes to T cell cross-priming
in vivo.
Uptake of Soluble Ag and Immune Complexes by DCs Is
Not Dependent on Functional CD169
To determine whether functional CD169 is important for other
types of Ag, we investigated the uptake of soluble antigen and
immune complexes by DC subsets in wild-type and Sn-KI
mice. Two hours after injection of Alexa 488-labeled OVA, a
similar percentage of all DC subsets was Alexa488-positive
and this was not changed in Sn-KI mice (Figures 6E, 6F, and
S6A). Similarly, the uptake of immune complexes of OVA-488
rabbit anti-OVA Ab was present in all DC subsets and not
affected by a non-functional CD169 molecule (Figures 6G, 6H,
Figure 4. DNGR-1 Expression on Cross-Presenting DCs Enhances Cross-Priming of CD8+ T Cell Responses
(A) Immunofluorescence staining of spleen sections for CD169+ macrophages on different time points after immunization (blue IgD, green CD169, red VCAM;
three mice per group). Left: without adjuvant. Middle: with adjuvant and anti-CD169. Right: with adjuvant and isotype control Ab. One representative picture of 3
mice/group is shown. Scale bar, 30 mm.
(B and C) Wild-type mice or DNGR1gfp/gfp mice were injected with 1 mg of the indicated Ab-biotin with 25 mg aCD40 and 25 mg poly(I:C). (B) Percentage of
biotin+ DCs and (C) geometric mean of biotin signal per DC subset. Mean ± SEM of one representative experiment of two with three mice per group is shown.
(D and E) Percentage of H-2Kb-SIINFEKL-tetramer+ CD8+ T cells (D) and percentage of OVA-specific IFNg-producing CD8+ T cells (E) after in vitro re-stimulation
with H-2Kb-restricted OVA257–264 peptide in C57BL/6- or DNGR-1-deficient mice 7 days after immunization. Graphs show mean ± SEM of 2 experiments
combined using 15mice/group. Statistical analysis one-way ANOVAwith Bonferroni’s multiple comparison test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001;
n.s., non-significant.
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and S6B). These results suggest that DCs directly take up
soluble Ag and immune complexes independently of CD169-
mediated interaction with macrophages.
Blocking CD169 Interactions Impairs T Cell Responses
after Modified Vaccinia Ankara Virus Infection
CD8+ T cell responses induced by modified vaccinia Ankara
(MVA) virus infection are dependent on BATF3-dependent
cross-presenting DCs and DNGR-1-mediated cross-priming
(Iborra et al., 2012, 2016). MVA infects CD169+ macrophages
in lymph nodes and induces cell death (Sagoo et al., 2016).
We infected mice with MVA virus in the footpad and analyzed
the effect of CD169-blocking antibodies on the MVA-specific
CD8+ T cell response in the draining lymph node and spleen
7 days after infection. The CD169-blocking Abs did not affect
CD169+ macrophage presence in spleen and lymph node (Fig-
ure S6B). We observed significantly decreased T cell responses
specific for the B8R immunodominant peptide from MVA in
both lymph nodes as well as spleen as detected by tetramer
staining and intracellular cytokine staining after in vitro
restimulation, which indicates that functional CD169 is neces-
sary to mediate cross-priming of MVA-specific CD8+ T cells
(Figures 7A–7C). Moreover, we found a significant decrease
in KLRG-1low cells when CD169 was blocked (Figure 7D), fitting
with a decrease in Ag cross-presentation and limited CD4+
Figure 5. CD169 Binds to CD8a+ DCs in a
Sialic Acid-Dependent Manner
(A–D) Binding of MAL-II and SNA lectins (a2,3
and a2,6-sialic acid specific) and recombinant
CD169-1Fc and CD169-R97A mutant to B220+ B
cells, Gr1+ CD11b+ neutrophils, and CD11c+MHC
class II+ DCs (A) and (B) and to CD8+ and CD8
CD11c+ MHC class II+ DCs (C) and (D).
(E) Binding of CD169-Fc to neuraminidase-treated
and non-treated DCs.
Geometric mean ± SEM of 3 mice/group and one
representative experiment from at least two inde-
pendent experiments is shown. Statistical analysis
one-way ANOVA with Bonferroni’s multiple com-
parison test. *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001; n.s., non-significant.
T cell help via BATF3-dependent DCs
(Eickhoff et al., 2015), while the numbers
of KLRG-1high cells were not affected
(Figure 7E). Together, our results indicate
that in MVA vaccinia virus infection
functional CD169 is necessary to obtain
optimal cross-presentation and induction
of CD8+ T cell responses.
In contrast to T cell responses after
MVA infection, T cell responses after intra-
venous vesicular stomatitis virus infection
were not influenced by blocking CD169-
binding to its ligands (Figure S6C). In
conclusion, our analysis of two different
viral models suggest that CD169-mediated
interaction between CD169+ macrophages
and CD8a+ DCs contributes to the generation of CD8+ T cell
immunity in those viral infections in which cross-presentation is
essential.
DISCUSSION
CD169+ macrophages in lymphoid organs are the first cells to
bind incoming pathogens and act as gatekeepers to prevent
further dissemination of pathogens. While their excellent
capacity to present Ags to B cells is well established, their spe-
cific role in the activation of T cell responses and the molecular
mechanisms of their interaction with cross-presenting DCs are
still not known. Our studies demonstrate unequivocally that
BATF3-dependent DCs and CD169+ macrophages have a
CD169-dependent interaction that facilitates Ag transfer and
DNGR1-mediated cross-presentation and thereby enables the
efficient induction of CD8+ T cell responses to viruses that
depend on cross-presentation.
Interestingly, a recent study on human DCs describes a
division of labor between DC subsets in which Ag acquisition
and Ag presentation functions are separated over different DC
subsets (Silvin et al., 2017). We propose a similar division of
labor for CD169+ macrophages and BATF3-dependent cross-
presenting DCs in the mouse. Multiple studies have illustrated
that CD169+ macrophages bind and are infected by different
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types of viruses (Bernhard et al., 2015; Honke et al., 2011; Junt
et al., 2007; Sagoo et al., 2016; Sewald et al., 2015). In the
case of VSV infection, this leads to enhanced local restricted
replication of the virus and the production of Ag that enhances
B and T cell responses (Honke et al., 2011). Vaccinia virus infec-
tion of CD169+ cells has been shown to lead to inflammasome
activation and cell death (Sagoo et al., 2016). Bacterial infection
and inflammatory agents induced disappearance of subcapsular
sinus CD169+ macrophages in the lymph node (Gaya et al.,
2015). Similarly, we observed the disappearance of splenic mar-
ginal zone CD169+ macrophages after injection with adjuvant.
Although we formally did not show CD169+ macrophage cell
death, we hypothesized that adjuvant-induced macrophage
cell death would lead to generation of ligands for DNGR-1
expressed on Batf-3-dependent DCs that would enable cross-
presentation of cell-associated antigens (Ahrens et al., 2012;
Iborra et al., 2012; Sancho et al., 2009; Zelenay et al., 2012).
Indeed, experiments in DNGR-1-deficient mice demonstrated
a role for DNGR-1 in the cross-priming of T cell responses after
Ag targeting to CD169+ macrophages, although we did not
observe a major role for adjuvant or DNGR-1 for Ag transfer to
DCs as has been previously reported (Iborra et al., 2012).
Figure 6. CD169 Promotes Ag Transfer and T Cell Cross-Priming
(A andB)Wild-type or Sn-KImicewere injectedwith 1 mg of the indicatedAb-488with 25mg aCD40and25 mg poly(I:C). (A) Percentage of Alexa488+DCsubsets and
(B) geometric mean of Alexa488 signal per DC subset two hours after injection using 3 mice/group. Mean ± SEM of one representative of 2 experiments is shown.
(C and D) Percentage of OVA-specific IFNg-producing CD8+ (C) and CD4+ (D) CD11a+ T cells after in vitro re-stimulation with H-2Kb-restricted OVA257–264 peptide
or I-Ab-restricted OVA262–276 peptide, respectively, in spleens of wild-type and Sn-KI mice 9 days after immunization with 1 mg of indicated Ab-OVA with 25 mg
aCD40 and 25 mg poly(I:C). Graphs show the combined mean ± SEM from 3 experiments of total 13 mice/group.
(E and F) Wild-type or Sn-KI mice were injected with 100 mg rabbit-anti-OVA Ab and 30 min later with 5 mg soluble Alexa488-labeled OVA, resulting in the
formation of immune complexes.
(G and H) Wild-type or Sn-KI mice were injected with 50 mg soluble Alexa488-labeled OVA.
(E–H) Percentage of Alexa488+DC subsets (E andG) and geometricmean of Alexa488 signal per DC subset (F andH) 2 hr after injection using 3mice/group.Mean
± SEM of one representative of two experiments is shown. Statistical analysis one-way ANOVA with Bonferroni’s multiple comparison test. *p < 0.05, **p <
0.01, ***p < 0.001, ****p < 0.0001; n.s., non-significant.
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Previously, CD169 was implicated in mediating binding of
CD169+ macrophages to lymphocytes, neutrophils, and innate
lymphocytes (Crocker et al., 1995; van den Berg et al., 1992;
Zhang et al., 2016). Here, we show strong CD169 binding to
DCs, and we propose that this adhesive function promotes
Ag transfer especially to BATF3-dependent CD8a+ cross-pre-
senting DCs. This pathway will possibly be less relevant for those
Ags and viruses that are likely to be taken up directly by DCs,
such as soluble Ag, immune complexes, and VSV. DCs express
multiple Fcg and complement receptors that enable immune
complex uptake and cross-presentation (den Haan and Bevan,
2002; vanMontfoort et al., 2007). In addition, effector T cell prim-
ing after VSV infection has been previously shown not to require
CD169+ macrophages (Ciavarra et al., 1997; Honke et al., 2011;
Iannacone et al., 2010). Interestingly, a recent study demon-
strated that specifically memory CD8+ T cell responses for VSV
were dependent on XCR1+ cross-presenting DCs and their inter-
action with CD169+ macrophages (Habbeddine et al., 2017).
Collectively, these studies indicate that XCR1+ BATF3-depen-
dent CD8a+ cross-presenting DCs are differentially required for
effector and memory CD8+ T cell responses in different viral
infections. Our results with the non-replicative vaccinia virus
infection model suggest that effector and memory T cell
responses that are dependent on cross-presenting DCs may
be influenced by CD169-mediated transfer of Ag.
Presentation by BATF3-dependent DCs serves as a platform
for CD4+ T cell help that is necessary for the generation of
long-term CD8+ T cell memory responses and mediates genera-
tion of CD8+ T cell resident memory responses (Eickhoff et al.,
2015; Hor et al., 2015; Iborra et al., 2016). Ag transfer from
CD169+ macrophages to BATF3-dependent DCs would
optimally facilitate the generation of these (resident) memory
CD8+ T cell responses. Indeed, we observed a decrease in
Figure 7. In Vivo Blockade of CD169 Impairs
the Activation of MVA-Specific CD8+ T Cell
Responses
(A–D) Percentage of MVA-specific IFNg-producing
CD8+ T cells in spleen (A) and LNs (B) after in vitro re-
stimulation with MVA-derived B8R+ peptide 7 days
after footpad infection with 5 3 105 PFU MVA in the
presence of CD169-blocking Abs or isotype control.
Percentage and number of B8R+ tetramer-specific
CD8+ T cells (C) and of KLRG1low B8R+ CD8+ T cells
(D) in LNs from mice 7 days after footpad infection.
(E) Number of KLRG1high B8R+ CD8+ T cells in LNs
frommice 7 days after footpad infection with 53 105
PFU MVA. Representative plots and mean ± SEM
from the combined data of two independent experi-
ments with a total of 10 mice/group are shown. Sta-
tistical analysis Student’s t test. *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001; n.s., non-significant.
KLRG-1low Ag-specific CD8+ T cells,
considered to have received CD4+ T cell
help, when CD169 interaction was blocked
during vaccinia virus. This would imply that
Ag transfer from CD169+ macrophages to
BATF3-dependent DCs is not only essential
for the generation of effector CD8+ T cell responses, but also en-
ables CD4+ T cell help and long-term memory T cell responses.
In conclusion, we demonstrate that CD169+ macrophages
interact with cross-presenting CD8a+ DCs in a CD169-depen-
dent manner and thereby enable Ag transfer, DNGR-1 stimula-
tion, and the cross-priming of CD8 T cell responses. We propose
that this collaboration is optimized for Ag acquisition and Ag
presentation to T cells, is physiologically relevant, and could
also be exploited for vaccination purposes.
EXPERIMENTAL PROCEDURES
Preparation of Monoclonal Antibody-OVA Conjugates
Purified rat IgG2a Ab aCD169 (MOMA-1), aDEC205 (NLDC145), and isotype
control (R7D4) were activated with SMCC (Pierce). Lipopolysaccharide
(LPS)-free OVA (Seikagaku) was functionalized with SATA (Pierce). After
removal of excess reagent and deacetylation of SATA, Abs were conjugated
with 5 equivalents (molar ratios) of OVA. Unconjugated OVA was removed
by gel filtration using a Superdex 200 column (Amersham).
Mice
C57Bl6/J, BATF3-deficient, andOT-Imicewere obtained fromCharles River or
the Jackson Laboratory. Sn-KImice inwhich Trp2 and Arg97 fromCD169were
changed to Gln and Ala, respectively, were generated at the University of Dun-
dee, and bred at the animal facility of the VU University Medical Center (Klaas
et al., 2012). Clec9agfp/gfp mice were bred at the animal facility of the CNIC in
Madrid, Spain (Sancho et al., 2009). All mice used in this study were matched
for age (8–12weeks) andsexandkept under specificpathogen-free conditions.
Experiments were approved by the Animal Ethics Committees of our institutes.
Immunizations
Mice were immunized intravenously (i.v.) with 1 mg monoclonal antibody
(mAb)-OVA in the presence or absence of 25 mg poly(I:C) and 25 mg aCD40
Ab (clone 1C10). Wild-type mice were treated with CD169-blocking Ab
(mix of 200 mg SER-4 and 100 mg 3D6) or isotype control Ab (300 mg R7D4)
at (day 1 or 2) and infected i.v. with 2 3 106 plaque-forming unit (PFU) of
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VSV or infected in the footpad with 5 3 105 PFU MVA. MVA-GFP was kindly
provided by Mariano Esteban (Di Pilato et al., 2013). VSV (Indiana strain,
Mudd-Summers isolate) was originally obtained from D. Kolakofsky. Virus
was propagated on BHK-21 hamster kidney fibroblasts at a MOI of 0.01.
Flow Cytometry
Stainings were performed after blocking Fc receptors with clone 2.4G2 for
30 min at 4C. For intracellular staining, cells were fixed in PBS containing
2% paraformaldehyde and stained in PBS with 0.5% BSA and 0.5% saponin.
Cells were analyzed using a Cyan ADP flow cytometer (Beckman Coulter),
Calibur (BD Bioscience), or Fortessa (BD Biosciences) and the Flowjo software
package (Tree Star). For gating strategies, see Figure S7.
Antibodies and Plant Lectins
The following antibodies were used from eBioscience: anti-B220 (clone RA3-
6B2), anti-CD11b (clone M1/70), anti-CD11c (clone N418), anti-Ly-6G/Gr-1
(clone RG6-8C5), anti-CD4 (Clone RM4-5), anti-CD11a (clone M17/4), anti-
IFNg (clone xM61.2), anti-VCAM-1 (clone 429), Fixable Viability Dye eFluor
780 and from Biolegend: anti-CD8a (clone 53-6.7), anti-VCAM-1 (clone
11-26c.2a). We produced and labeled the following antibodies in house:
anti-MHC-II (clone M5/114), anti-CD169 (clones MOMA-1-488 or SER-4-
488), isotype control (clone R7D4). Plant lectins were obtained from vector
labs: Maackia Amurensis Lectin II (MALII) and Sambucus Nigra Lectin (SNA).
Sytox blue nucleic acid stain (Invitrogen).
Immunofluorescence
Tissue sections were cut at 5–6 mM Mikrom HM 560 cryostat, fixed in 100%
acetone, stained, and analyzed with a LEICA DM6000 or Leica TCS SP8
equipped with a pulsed white light laser and HyD hybrid detector equipped
with temporal gating. LAS AF software was used for acquisition and ImageJ
for image processing subsequent to data acquisition. Huygens professional
deconvolution software was used for deconvolution.
Histocytometry
Spleen tissue was cryosectioned at 16 mM, and sections were rehydrated in
0.1 M Tris buffer for 30 min and blocked with blocking buffer (0.1 M Tris buffer,
0.02% Triton X-100, 1% normal mouse serum, anti-CD16/32 blocking Ab, 1%
BSA) for 1 hr. Tissue sections were stained with directly labeled primary anti-
bodies in blocking buffer for 16 hr at 4C. After an extensive wash with 0.1 M
Tris buffer, sections were mounted in Fluoromount-G (Thermo Fisher). Nuclei
were counterstained with JOJO-1 Iodide (Thermo Fisher). Whole spleen cross-
sections were acquired (voxel size y-x = 240 nm, z = 1 mm) on a Leica TCS SP8
confocal microscope with tunable pulsed white-light laser, 405 nm violet laser,
and Leica HyD hybrid detectors. After acquisition, the tiled images were
merged and compensated using the LAS X Merge and Channel Dye Separa-
tion module, respectively. Next, 3D stacked and compensated images were
analyzed using histocytometry in Imaris 7.4 (Bitplane) and FlowJo as
previously described (Gerner et al., 2012). In short, CD169 signal was
used to segment CD169+ macrophages by surface rendering and splitting
individual cells using the Surface Module. The segmentation of dendritic cells
was obtained by first creating a masking channel by selecting for
B220CD3MHCII+CD11c+ voxels. The expression of CD4, CD8, MHCII,
and CD11c on this masking channel was used as ‘‘true’’ DC expression of
these markers. Next, a ‘‘dendritic cell’’ channel was created by combining
CD11c+ MHCII+ voxels on the B220CD3MHCII+CD11c+ mask. This channel
was used to segment and split individual dendritic cells using the Imaris
Surface Module (Bitplane). Next, individual surfaces were exported to FlowJo
and used for gating and figure representation.
Analysis of CD8 and CD4 T Cell Responses
Splenocytes frommice 7 days after i.v. immunization were re-stimulated in vitro
for 5–6 hr with MHC class I restricted OVA257–264 peptide (0.1 mg/mL), MVA-
derived B8R20–27 peptide, or VSV antigen p8 peptide or p52 peptide including
GolgiPlug or Brefeldin A or for 18 hrwithMHCclass II restrictedOVA262–276 pep-
tide (100mg/mL) followedby5hr incubationwithGolgiPlug (BDBiosciences). For
tetramer stainings, splenocytes were incubated 45min at 37Cwith PE-labeled
H2-Kb:SIINFEKL tetramers (generated at LUMC, Leiden, the Netherlands) in the
presence of anti-CD8Ab (clone 53-6,7). APC-labeledH-2Kb B8R20–27 tetramers
were provided by the NIH Tetramer Facility at Emory University.
Spleen Digestion
Spleens were cut and incubated in 1 mL per spleen of 2 WU/mL Liberase I
(Roche Diagnostics GmbH, Mannheim, Germany) and 50 mg/mL DNase I
(Roche) in medium without fetal calf serum (FCS) and b-mercaptoethanol with
continuousstirringat 37C for15min.EDTAwasadded toa10mMfinal concen-
tration, and thecell suspensionwas incubated foranadditional 5minat4C.Red
blood cells were lysed with ammonium-chloride-potassium lysis buffer. Cells
werewashed once and undigestedmaterial was removed by a 70–100 mMfilter.
Ex Vivo Ag Presentation Assays
Mice were injected i.v. with 1 mg mAb-OVA plus 25 mg aCD40 and 25 mg poly
(I:C). After 16 hr, DCs from 5–15 spleens were purified with anti-CD11c MACS
microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and co-cultured
(2.5 3 105) with purified OT-I T cells (105) in triplicate in flat-bottomed
96-well plates. As a positive control, DCs were incubated with 1 mg/mL
MHC class I OVA257–264 peptide for 1 hr and washed three times. After
48 hr, plates were pulsed with 1 mCi/well of [3H]-thymidine. After an additional
16 hr, [3H]-thymidine incorporation was measured on a Wallac-LKB Betaplate
1205 liquid scintillation counter. Data were summarized by themean and SEM.
In Vivo Ag Transfer Assays
Micewere immunized i.v. with 1 mgmAb-Alexa488 ormAb-biotin in the presence
or absenceof 25mgpoly(I:C) and 25mgaCD40Ab1C10. Tenminutes or 2 hr after
injection, mice were sacrificed and spleens were digested for fluorescence-
activated cell sorting (FACS) analysis or frozen for immunofluorescence analysis.
Imaging Flow Cytometry
After digestion, splenocytes from three mice were pooled, stained for surface
markers, and fixed in 2% paraformaldehyde. Cells were analyzed using the Im-
ageStreamX (Merck Millipore) imaging flow cytometer. Internalization scores
were calculated as previously described (Garcı´a-Vallejo et al., 2014). In short,
a mask was designed based on the bright-field morphology image that was
eroded until the membrane was left out of the mask. Alexa488 signal within
this mask was defined as intracellular, while Alexa488 signal outside was
defined asmembrane-associated. The internalization score was calculated us-
ing the internalization feature provided in Ideas v6.0 software (Merck Millipore).
Scores below 0 indicate that themajority of the signal ismembrane-associated,
while scores above 0 indicate that the majority of the signal is intracellular.
Lectin and CD169 Binding Assays and Neuraminidase Treatment
Biotinylated plant lectins from Maackia amurensis Lectin-II (MAL-II) and Sam-
bucus nigra (SNA) were incubated with DCs for 30 min at 37C in TSM buffer
(20 mM Tris [pH 7.4], 150 mM NaCl, 1 mM CaCl2, and 2 mMMgCl2) with 0.5%
BSA (Fluka Biochemika), followed by additional stainings at 4C. For CD169-
Fc binding assays, DCs were incubated with pre-complexed CD169-Fc or
CD169-Fc-R97A (1–10 mg/mL) with goat-anti-Human-Fc-Alexa488 (0.5 mg/
mL, Invitrogen) in TSM buffer with 1% BSA (Fluka Biochemika) for 45 min at
room temperature or 1 hr on ice and analyzed by flow cytometry. For neur-
aminidase treatment cells were incubated in DMEM without FCS with 1:60
sialidase (Sigma) for 1 hr at 37C and mixed gently every 15 min.
Statistical Analysis
Statistical significance was tested using GraphPad Prism by performing a
two-tailed student-t test, ANOVA with Bonferroni’s correction, or a Kruskal-
Wallis test with Bonferroni’s correction (*p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001; n.s., non-significant). N represents the number of animals
used in the experiment.
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